Melanoma risk increased after radioactive iodine treatment for primary thyroid cancer, study finds

Patients with primary thyroid cancer who receive radioactive iodine therapy have an elevated risk for melanoma and other nonkeratinocyte skin cancers when limiting the cancer site to the head and neck, according to a study published online Sept. 19 in JAMA Network Open.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup